• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种诊断儿童非甾体抗炎药过敏的方法。

Two approaches for diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity in children.

机构信息

Division of Pediatric Allergy and Immunology, Kocaeli University, Kocaeli, Turkey.

Division of Pediatric Allergy and Immunology, Kocaeli University, Kocaeli, Turkey.

出版信息

Ann Allergy Asthma Immunol. 2019 Oct;123(4):389-393. doi: 10.1016/j.anai.2019.07.005. Epub 2019 Jul 16.

DOI:10.1016/j.anai.2019.07.005
PMID:31323315
Abstract

BACKGROUND

The oral provocation test (OPT) with culprit drug is the gold standard in the diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity (NSAID-H). Some authors have proposed that the total number of OPTs required to diagnose NSAID-H is much lower with acetyl salicylic acid (ASA) provocations, regardless of patients' reaction history, and less time consuming.

OBJECTIVE

This study aims to evaluate the total number of OPTs required to confirm NSAID-H according to the drugs (ASA or culprit NSAID) used in the initial OPT.

METHODS

The study included patients with a history of NSAID-H. Data on the demographic and clinical features, coexisting chronic or allergic disease, and laboratory results were collected from medical records. The drug used for the initial OPT (ASA or culprit NSAID), results of the OPT, and the total number of OPTs were reviewed.

RESULTS

We included 56 children with suspected hypersensitivity reaction to NSAIDs. NSAID-H was confirmed in 21 children (37.5%). We calculated that if all OPTs were performed with culprit drugs as an initial choice, the number of OPTs required for diagnosis would be 3 or more in 85.7% of positive cases. The number of episodes was an independent risk factor for NSAID-H by multiple logistic regression analysis (odds ratio, 4.3; 95% confidence interval, 1.48-12.24; P = .007).

CONCLUSION

Performing an initial OPT with ASA regardless of patients' reaction history can result in much lower numbers of OPT to diagnose NSAID-H and can improve patient compliance.

摘要

背景

口服激发试验(OPT)是诊断非甾体抗炎药过敏(NSAID-H)的金标准,使用 culprit 药物进行 OPT。一些作者提出,对于乙酰水杨酸(ASA)激发试验,无论患者的反应史如何,诊断 NSAID-H 所需的 OPT 总数要低得多,而且耗时更少。

目的

本研究旨在评估根据初始 OPT 中使用的药物(ASA 或 culprit NSAID)来确定 NSAID-H 所需的 OPT 总数。

方法

研究纳入了有 NSAID-H 病史的患者。从病历中收集了人口统计学和临床特征、共存的慢性或过敏性疾病以及实验室结果的数据。回顾了初始 OPT 中使用的药物(ASA 或 culprit NSAID)、OPT 的结果以及 OPT 的总数。

结果

我们纳入了 56 名疑似对 NSAIDs 过敏的儿童。21 名儿童(37.5%)确诊为 NSAID-H。我们计算得出,如果所有 OPT 均使用 culprit 药物作为初始选择,则在 85.7%的阳性病例中,诊断所需的 OPT 数量将为 3 次或更多。多次逻辑回归分析显示,发作次数是 NSAID-H 的独立危险因素(优势比,4.3;95%置信区间,1.48-12.24;P =.007)。

结论

无论患者的反应史如何,进行初始 OPT 时使用 ASA 都可以降低诊断 NSAID-H 所需的 OPT 数量,并提高患者的依从性。

相似文献

1
Two approaches for diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity in children.两种诊断儿童非甾体抗炎药过敏的方法。
Ann Allergy Asthma Immunol. 2019 Oct;123(4):389-393. doi: 10.1016/j.anai.2019.07.005. Epub 2019 Jul 16.
2
Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children.经证实可引发儿童非甾体抗炎药过敏的药物。
Allergy. 2013 Dec;68(12):1555-61. doi: 10.1111/all.12266. Epub 2013 Oct 11.
3
The value of the clinical history for the diagnosis of immediate nonsteroidal anti-inflammatory drug hypersensitivity and safe alternative drugs in children.临床病史对儿童即刻非甾体抗炎药超敏反应诊断及安全替代药物的价值。
Allergy Asthma Proc. 2016 Jan-Feb;37(1):57-63. doi: 10.2500/aap.2016.37.3917.
4
Different Phenotypes of Non-Steroidal Anti-Inflammatory Drug Hypersensitivity during Childhood.儿童期非甾体抗炎药超敏反应的不同表型
Int Arch Allergy Immunol. 2015;167(3):211-21. doi: 10.1159/000438992. Epub 2015 Aug 29.
5
Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis.非甾体抗炎药超敏反应综合征。一项多中心研究。I. 临床发现与体外诊断。
J Investig Allergol Clin Immunol. 2009;19(5):355-69.
6
Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children.儿童非甾体抗炎药超敏反应诊断与分类中的差异
Allergol Int. 2017 Jul;66(3):418-424. doi: 10.1016/j.alit.2016.10.004. Epub 2016 Nov 16.
7
Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity.非甾体抗炎药激发试验结果与非甾体抗炎药过敏儿童分类困难。
Ann Allergy Asthma Immunol. 2020 Aug;125(2):202-207. doi: 10.1016/j.anai.2020.04.003. Epub 2020 Apr 12.
8
A Multicenter Retrospective Study on Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Children: A Report from the European Network on Drug Allergy (ENDA) Group.一项关于儿童非甾体抗炎药(NSAIDs)超敏反应的多中心回顾性研究:来自欧洲药物过敏网络(ENDA)小组的报告。
J Allergy Clin Immunol Pract. 2020 Mar;8(3):1022-1031.e1. doi: 10.1016/j.jaip.2019.10.049. Epub 2019 Nov 27.
9
Acetyl Salicylic Acid Challenge in Children with Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs Differentiates Between Cross-Intolerant and Selective Responders.乙酰水杨酸激发试验在非甾体类抗炎药过敏反应患儿中鉴别交叉过敏和选择性反应者。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1226-1235. doi: 10.1016/j.jaip.2017.08.029. Epub 2017 Oct 3.
10
Nonsteroidal anti-inflammatory drug hypersensitivity among children.儿童非甾体抗炎药超敏反应
Allergy Asthma Proc. 2015 Sep-Oct;36(5):386-93. doi: 10.2500/aap.2015.36.3858.

引用本文的文献

1
Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement.更新非甾体抗炎药超敏反应的分类与常规诊断:世界变态反应组织声明
World Allergy Organ J. 2025 Aug 12;18(8):101086. doi: 10.1016/j.waojou.2025.101086. eCollection 2025 Aug.
2
Diagnostic evaluation of hypersensitivity reactions to arylpropionic acid derivatives: a descriptive observational study focusing on clinical characteristics and potential risk factors in children.芳香基丙酸衍生物过敏反应的诊断评估:一项描述性观察研究,重点关注儿童的临床特征和潜在危险因素。
Int J Clin Pharm. 2024 Dec;46(6):1294-1306. doi: 10.1007/s11096-024-01756-4. Epub 2024 Jun 11.
3
Nonsteroidal anti-inflammatory drug hypersensitivity in a pediatric severe asthmatic population.
非甾体抗炎药过敏在儿童严重哮喘人群中的表现。
Pediatr Pulmonol. 2023 Oct;58(10):2983-2986. doi: 10.1002/ppul.26618. Epub 2023 Jul 28.
4
Recent Updates in Understanding NSAID Hypersensitivity.非甾体抗炎药超敏反应认识的最新进展
Curr Allergy Asthma Rep. 2023 Mar;23(3):181-188. doi: 10.1007/s11882-023-01064-3. Epub 2023 Feb 9.
5
NSAID Hypersensitivity in the Pediatric Population: Classification and Diagnostic Strategies.儿科人群中的非甾体抗炎药超敏反应:分类与诊断策略
J Asthma Allergy. 2022 Sep 28;15:1383-1399. doi: 10.2147/JAA.S267005. eCollection 2022.
6
Drug Allergy in children: focus on beta-lactams and NSAIDs.儿童药物过敏:聚焦于β-内酰胺类药物和非甾体抗炎药。
Acta Biomed. 2020 Sep 15;91(11-S):e2020008. doi: 10.23750/abm.v91i11-S.10312.